EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drugs and genetics: an integrated approach to undergraduate pharmacology education

Colleen Carpenter-Swanson

Frontiers in Pharmacology · 20.11.2026 · 17

DOI: 10.3389/fphar.2026.1957820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.11.2026. Verfasst von Colleen Carpenter-Swanson. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drugs and genetics: an Introduction to Personalized Medicine (BIOL 348) is an upper-level undergraduate course examining the scientific and societal dimensions of pharmacology and genomics, focusing on how these fields shape individualized treatment strategies. The course tackles big questions such as: What is a drug? Why do not drugs work the same in everyone? And how can genetic insights improve the drug discovery pipeline? Students engage with foundational pharmacological principles (pharmacokinetics, pharmacodynamics, receptor theory, etc.) through lectures, primary literature discussions, hands-on laboratory work with zebrafish and CRISPR, and real-world case studies. A central theme is neuropharmacology, explored through the lens of epilepsy, where students use zebrafish to model seizure activity and test the effects of established and experimental antiseizure drugs. Beyond epilepsy, students explore the application of pharmacological principles to other central nervous system conditions, including anxiety disorders, schizophrenia, and substance use disorders. The course features guest speakers from academia, regulatory science, pharmaceutical development, and genetic counseling, offering exposure to diverse career paths in pharmacology. To promote equity and engagement, students create an educational video explaining their experiments in accessible language and present it to local middle schoolers during an end-of-semester demonstration day. This submission describes the structure and implementation of the course, along with anonymized, university-administered Student Evaluation of Instruction (SEI) data and descriptive performance on common course-embedded assessments from Spring 2023, Spring 2024, and Fall 2025. In all semesters, students rated the course highly in areas such as the educational value of the laboratory component, increased knowledge of the subject, and stimulation of critical and analytical thinking. Written feedback also emphasized the strong integration of laboratory and lecture content. Median aggregate quiz performance across the three offerings ranged from 85.0% to 87.5%, median Exam I performance from 85.0% to 90.0%, and median Exam II performance from 86.0% to 89.3%. These course-performance data complement, rather than replace, the SEI findings and are not interpreted as pre/post learning gains. This case study offers a practical and interdisciplinary model for pharmacology education. It centers curiosity, hands-on experimentation, and career exploration, helping students connect core scientific concepts to real-world contexts and future opportunities.

Zitieren

APA

Carpenter-Swanson, C. (2026). Drugs and genetics: an integrated approach to undergraduate pharmacology education. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1957820

Vancouver

Carpenter-Swanson C. Drugs and genetics: an integrated approach to undergraduate pharmacology education. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1957820

BibTeX
@article{CarpenterSwanson2026,
  author = {Carpenter-Swanson, Colleen},
  title = {Drugs and genetics: an integrated approach to undergraduate pharmacology education},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1957820}
}
Kostenlos starten →